Aitziber Buqué Martinez, PhD
Post-Doctoral Associate
Oct 2017 – Sep 2022

(Co)-first Authored Publications

  1. Buqué, A. and L. Galluzzi. Emergent impact of lifestyle on tumor progression and response to therapy. Int Rev Mol Cell Biol, 2022. 373: p. ix-xvii.
  2. Petroni, G., Buqué, A., Coussens, L.M. and L. Galluzzi. Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nat Rev Drug Discov, 2022. 22(6): p. 440-462.
  3. Buqué, A., Galluzzi, L. and G. Kroemer. Ketosis versus carbotoxicity – Metabolism determines the outcome of cancer immunotherapy. Mol Cell Oncol, 2021. 8(1): p. 1868266.
  4. Buqué, A., Perez-Lanzón, M., Petroni, G. et al. MPA/DMBA-driven mammary carcinomas. Methods Cell Biol, 2021. 163: p. 1-19.
  5. Buqué, A. and L. Galluzzi. Chemical carcinogenesis in mice as a model of human cancer: Pros and cons. Methods Cell Biol, 2021. 163: p. xvii-xxv.
  6. Buqué, A., Galluzzi, L. and D.C. Montrose. Targeting serine in cancer: Is two better than one? Trends Cancer, 2021. 7(8): p. 668-670.
  7. Buqué, A., Bloy, N., Kroemer, G. and L. Galluzzi. Possible mechanisms of cancer prevention by nicotinamide. Br J Pharmacol, 2021. 178(10): p. 2034-2040.
  8. Petroni, G., Buqué, A., Zitvogel, L., Kroemer, G. and L. Galluzzi. Immunomodulation by targeted anticancer agents. Cancer Cell, 2021. 39(3): p. 310-345.
  9. Buqué, A., Bloy, N., Perez-Lanzón, M. et al. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nat Commun, 2020. 11(1): p. 3819.
  10. Buqué, A., Bloy, N., Petroni, G., Kroemer, G. and L. Galluzzi. NK cells beat T cells at early breast cancer control. Oncoimmunology, 2020. 9(1): p. 1806010.
  11. Buqué, A., Rodriguez-Ruiz, M.E., Fucikova, J. and L. Galluzzi. Apoptotic caspases cut down the immunogenicity of radiation. Oncoimmunology, 2019. 8(11): p. e1655364.
  12. Rodriguez-Ruiz, M.E., Buqué, A., Hensler, M. et al. Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. Oncoimmunology, 2019. 8(11): p. e1655964.
  13. Buqué, A., Galluzzi, L. and N. Casares. Today’s special on the anticancer menu: Immunomodulation by antifolates. Clin Cancer Res, 2019. 25(23): p. 6890-6892. 
  14. Buqué, A. and L. Galluzzi. Modeling tumor immunology and immunotherapy in mice. Trends Cancer, 2018. 4(9): p. 599-601. 

(Co)-senior Authored Publications 

  1. Sato, A., Bloy, N., Galassi, C., Jiménez-Cortegana, C. et al. Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis. Methods Cell Biol, 2022. 172: p. 115-134.
  2. Buqué, A. and L. Galluzzi. Emergent impact of lifestyle on tumor progression and response to therapy. Int Rev Mol Cell Biol, 2022. 373: p. ix-xvii.

Abstracts selected for Travel Awards (First/co-first and last/co-last only)

  1. Buqué, A., Perez-Lanzón, M., Yamazaki, T. et al. Radiation therapy breaks through the resistance of HR+ breast cancer to immune checkpoint blockers in an endogenous mouse model of disease. 3rd International Conference on Radiotherapy Immunotherapy Combinations (Paris, France, September 2018).

Abstracts selected for Oral Presentation (First/co-first and last/co-last only)

  1. Buqué, A., Bloy, N., Petroni, G. et al. Breaking through the resistance of HR+ breast cancer to immunotherapy. 5th International Conference on Radiotherapy Immunotherapy Combinations (Paris, France, September 2021).
  2. Buqué, A., Bloy, N., Petroni, G. et al. NK cells beat T cells at breast cancer control. Institutional Seminar of the Charles University (Prague, Czech Republic, October 2019).

Abstracts Selected for Poster Presentation (First/co-first and last/co-last only)

  1. Buqué, A., Picatoste, M.B., Bloy, N. et al.  Role of insulin resistance in HR+ mammary carcinogenesis. 2022 San Antonio Breast Cancer Symposium (San Antonio, TX, US, December 2022).
  2. Buqué, A., Yamazaki, T., Galluzzi L. and S.C. Formenti. Synergistic effect of hypofractionated radiation and PD-1 blockage in an endogenous model of HR+ breast cancer. 61th Annual ASTRO Meeting (Chicago, IL, US, September 2019). 
  3. Buqué, A., Rodriguez-Ruiz, M.E., Hensler, M. et al. Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. 4th International Conference on Radiotherapy Immunotherapy Combinations (New York, NY, US, September 2019).
  4. Buqué, A., Perez-Lanzón, M., Yamazaki, T. et al. Nutritional measures to boost immunosurveillance of breast cancer by NK cells. 32nd Annual SITC Meeting (National Harbor, MD, US, November 2017).

Other Achievements

  1. Arthur and Sandra Irving Cancer Immunology Symposium Trainee (2022).
  2. SITC Sparkathon 2.0 Accelerator Trainee (2021-2022).
  3. SITC Early Career Scientist Committee Member (2021).
  4. SITC Women in Cancer Immunotherapy Network (WIN) Member (2021). 

Career Advancements

  1. Instructor of Cell Biology in Radiation Oncology. Dept. of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. Oct 2022 – Apr 2024.
  2. Assistant Professor, Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. Apr 2024 – Present.

My Bibliography Link

https://www.ncbi.nlm.nih.gov/myncbi/1LSbeEpYfo5AD/bibliography/public/